Posted on

3 tips for biotech startups seeking non-dilutive capital to survive the downturn

James Coates Contributor James Coates is the Health and Human Performance principal at Decisive Point, a venture capital and advisory firm that invests in and supports startups with emerging defense […]




Posted on

Meta Pharmaceuticals lands $15M to make autoimmune drugs with AI, new immuno-metabolism tech

Biotech startup Meta Pharmaceuticals sets itself an ambitious goal as it secures its initial investment. The Shenzhen-based company, which sets out to develop treatments for autoimmune diseases with the help […]







Posted on

Mayfield’s Arvind Gupta discusses startup fundraising during a downturn

Between his roles as co-leader of Mayfield Fund’s engineering biology practice and founder at IndieBio, Arvind Gupta reviewed approximately 470 startup pitches last year. He characterizes his process as “simple,” […]







Posted on

Sectors where New Zealand startups are poised to win

As a remote island nation in the middle of the South Pacific, New Zealand is experiencing the stirrings of a burgeoning startup scene. The country has historically been capital-starved, but […]




Posted on

Phylagen, which tracks indoor microbiomes, says it’s right now “racing to meet demand”

Two years into a worldwide pandemic, outfits around the globe are wrestling with how to resume their in-person operations safely. Consider that Apple just scrapped its office-return deadline, while Google, […]




Posted on

Primer Sazze Partners closes $127M second fund aimed at South Korean entrepreneurs

Primer Sazze Partners, a San Jose-based venture capital firm, announced today it has raised its second fund at $127 million (150 billion won) to invest in startups founded by Korean […]




Posted on

Generate Biomedicines raises $370M Series B with a focus on protein-based drugs

The drug development space is continuing to attract more and more investment. On Thursday, another major player, Generate Biomedicines, announced a $370 million Series B round.  Generate Biomedicines is touting […]